Anita I. Kapanen - Concepedia

Author

Anita I. Kapanen

University of British Columbia ORCID

Also Known As

A I Kapanen, A Kapanen, A. Kapanen, A.I. Kapanen, Anita I Kapanen, Anita I. Kapanen, Anita Kapanen, Kapanen, Anita I.

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia University of Oulu BC Cancer Agency Tampere University Hospital University of Turku

About

Anita I. Kapanen is an author at University of British Columbia specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.1K
2	Cell Biology	6	6	1.3K
3	Engineering	4	4	262
4	Biomedical Engineering	1	1	34
5	Cellular Physiology	1	1	110

Anita I. Kapanen

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab Minna Tanner, Maija Hollmén, Teemu T. Junttila, Annals of Oncology Intestinal TypeOncologyGastrointestinal OncologyMedicinePathology	2005	656
Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line Péter Nagy, Elza Friedländer, Minna Tanner, Cancer Research Erbb2 Gene AmplificationBreast OncologyG Protein-coupled ReceptorReceptor Tyrosine KinaseImmunology	2005	509
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer Minna Tanner, Anita I. Kapanen, Teemu T. Junttila, Molecular Cancer Therapeutics Tumor BiologyBreast OncologyNovel Cell LineClinical ResistanceHerceptin-resistant Breast Cancer	2004	267
Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture Qiang Qu, M. Perälä-Heape, Anita I. Kapanen, Bone Developmental BiologyBone Morphogenic ProteinBone RepairGynecologyEstrogen Enhances Differentiation	1998	246
Trastuzumab causes antibody-dependent cellular cytotoxicity–mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance Márk Barok, Jorma Isola, Zsuzsanna Pályi‐Krekk, Molecular Cancer Therapeutics	2007	235
Effect of nickel–titanium shape memory metal alloy on bone formation Anita I. Kapanen, Jorma Ryhänen, A. Danilov, Biomaterials Materials ScienceEngineeringAlloy DesignBone FormationMetal Forming	2001	131
Behaviour of Nitinol in osteoblast-like ROS-17 cell cultures Anita I. Kapanen, Joanna Ilvesaro, A. Danilov, Biomaterials Tissue CultureMedicineCell BiologyCellular PhysiologyOsteocalcin	2002	110
Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer Wieslawa H. Dragowska, Sherry A. Weppler, Jun Chih Wang, PLoS ONE MitophagyBreast OncologyEarly ResponseTyrosine KinaseCell Death	2013	98
Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy A.M. Thomas, Anita I. Kapanen, Jennifer I. Hare, Journal of Controlled Release NanoparticlesNanomedicinePharmaceutical ScienceLipid PreparationEngineering	2010	75
Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs Gigi N.C. Chiu, Lincoln Edwards, Anita I. Kapanen, Molecular Cancer Therapeutics	2007	59

Page 1